Celltrion, Inc. (KRX:068270)
179,400
-900 (-0.50%)
Sep 18, 2026, 3:30 PM KST
Celltrion Market Cap
Celltrion has a market cap or net worth of 40.98 trillion as of September 18, 2026. Its market cap has increased by 10.47% in one year.
Market Cap
40.98T
Enterprise Value
43.74T
Revenue
4.90T
Ranking
n/a
PE Ratio
26.23
Stock Price
179,400.00
ChartMarket Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 40.98T, an increase of 39,379.65%. That is a compound annual growth rate of 39.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 40.98T | 3.48% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.15T |
| ALTEOGEN | 17.79T |
| Samsung Epis Holdings | 8.12T |
| SK Biopharmaceuticals | 6.12T |
| HLB Co., Ltd. | 4.24T |
| Peptron | 3.42T |
| ABL Bio | 3.24T |
| LigaChem Biosciences | 3.04T |